For drug products delivered through the skin, In Vitro Release Testing (IVRT) and In Vitro Permeation Testing (IVPT) help the pharmaceutical industry meet regulatory requirements for demonstrating bioequivalence (BE).

Our unmatched leadership in IVRT/IVPT technologies helps Sponsors obtain FDA biowaivers for generic dermatological products, avoiding high-cost, time-consuming in vivo BE studies.

Whether you are developing a new drug or seeking regulatory approval, we provide method development and validation services for creams, lotions, ointments, gels, pastes, less viscous solutions and suspensions, and transdermal patches.

Learn how we can help you analyze your topical pharmaceutical to meet compliance requirements.


Learn More